Guidance for laboratories performing molecular pathology for cancer patients

Higher Quality of Molecular Testing, an Unfulfilled Priority

(2014) Lien Tembuyser et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Molecular Pathology Curriculum for Medical Laboratory Scientists

(2014) Sara Taylor et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Next generation diagnostic molecular pathology: Critical appraisal of quality assurance in Europe

(2014) Hendrikus J. Dubbink et al.   Molecular Oncology

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

(2014) C. Bettegowda et al.   Science Translational Medicine

Analysis of the effect of various decalcification agents on the quantity and quality of nucleic acid (DNA and RNA) recovered from bone biopsies

(2013) Veena M. Singh et al.   Annals of Diagnostic Pathology

European Consensus Conference for external quality assessment in molecular pathology

(2013) J. H. van Krieken et al.   ANNALS OF ONCOLOGY

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

(2013) Neal I. Lindeman et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Detection ofEGFRmutations andEML4-ALKrearrangements in lung adenocarcinomas using archived cytological slides

(2013) Natalia V. Mitiushkina et al.   CANCER CYTOPATHOLOGY

Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies

(2013) Tianhong Li et al.   JOURNAL OF CLINICAL ONCOLOGY

Results of the First Italian External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non–Small-Cell Lung Cancer

(2013) Nicola Normanno et al.   Journal of Thoracic Oncology

Liquid biopsy: monitoring cancer-genetics in the blood

(2013) Emily Crowley et al.   Nature Reviews Clinical Oncology

Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition

(2013) Dimo Dietrich et al.   PLoS One

Closing the Quality Loop: Facilitating Improvement in Oncology Practice Through Timely Access to Clinical Performance Indicators

(2013) John Srigley et al.   Journal of Oncology Practice

High concordance ofEGFRmutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas

(2012) Ping-Li Sun et al.   CANCER CYTOPATHOLOGY

The Genetic Basis for Cancer Treatment Decisions

(2012) Janet E. Dancey et al.   CELL

Developing National Guidance on Genetic Testing for Breast Cancer Predisposition: The Role of Economic Evidence?

(2012) William Sullivan et al.   Genetic Testing and Molecular Biomarkers

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

(2012) Nicola Normanno et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Guidance on the development and validation of diagnostic tests that depend on nucleic acid amplification and detection

(2012) Nick Saunders et al.   JOURNAL OF CLINICAL VIROLOGY

Implementation of Formalin-Fixed, Paraffin-Embedded Cell Line Pellets as High-Quality Process Controls in Quality Assessment Programs for KRAS Mutation Analysis

(2012) Jeroen R. Dijkstra et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

(2012) T. Forshew et al.   Science Translational Medicine

KRAS mutation analysis on low percentage of colon cancer cells: the importance of quality assurance

(2012) J. R. Dijkstra et al.   VIRCHOWS ARCHIV

Guideline on the requirements of external quality assessment programs in molecular pathology

(2012) J. Han van Krieken et al.   VIRCHOWS ARCHIV

The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research

(2011) DG Hicks et al.   BIOTECHNIC & HISTOCHEMISTRY

Circulating tumour markers can define patients with normal colons, benign polyps and cancers

(2011) R Mead et al.   BRITISH JOURNAL OF CANCER

Preparing pathology for personalized medicine: possibilities for improvement of the pre-analytical phase

(2011) Patricia J T A Groenen et al.   HISTOPATHOLOGY

Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables

(2011) Yalai Bai et al.   LABORATORY INVESTIGATION

The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group

(2011) Erik Thunnissen et al.   LUNG CANCER

External Quality Assessment for KRAS Testing Is Needed: Setup of a European Program and Report of the First Joined Regional Quality Assessment Rounds

(2011) E. Bellon et al.   ONCOLOGIST

Formalin Fixation at Low Temperature Better Preserves Nucleic Acid Integrity

(2011) Gianni Bussolati et al.   PLoS One

KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment

(2011) Nicola Normanno et al.   PLoS One

Molecular basis of chemosensitivity of platinum pre-treated ovarian cancer to chemotherapy

(2010) S Glaysher et al.   BRITISH JOURNAL OF CANCER

Approaches to quality management and accreditation in a genetic testing laboratory

(2010) Sarah Berwouts et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

A Brief Retrospective Report on the Feasibility of Epidermal Growth Factor Receptor and KRAS Mutation Analysis in Transesophageal Ultrasound- and Endobronchial Ultrasound-Guided Fine Needle Cytological Aspirates

(2010) Olga C.J. Schuurbiers et al.   Journal of Thoracic Oncology

Multicentre validation study of nucleic acids extraction from FFPE tissues

(2010) Serena Bonin et al.   VIRCHOWS ARCHIV

External Quality Assurance of HER2 FISH and ISH Testing

(2008) John M.S. Bartlett et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY